Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
San Jose, California, Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center: The San Jose, California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that governs the use and licensing of collateral created as a result of their collaborative research efforts. This agreement establishes the intellectual property rights and usage rights associated with the collateral, ensuring fair and mutually beneficial terms for both parties involved. In this agreement, Gentling, Inc. grants The University of North Texas Health Science Center a license to use and commercialize any collateral generated through their joint research projects. The collateral may include but is not limited to patents, copyrights, trademarks, trade secrets, and other forms of intellectual property. The agreement outlines the specific terms and conditions regarding the use, disclosure, and protection of this collateral. The purpose of this agreement is to formalize the relationship between Gentling, Inc. and The University of North Texas Health Science Center, ensuring that both parties have a clear understanding of their rights and obligations regarding the collateral. By establishing a licensing framework, it enables the university to further develop and commercialize the collateral, while also acknowledging Gentling, Inc.'s contribution to its creation. Furthermore, this collaborative agreement lays out the financial terms, including potential royalties or compensation that may be due to Gentling, Inc. based on the commercial success of the collateral. It also addresses confidentiality and non-disclosure provisions to protect any sensitive information shared during the research process. Different types of San Jose, California Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may exist depending on the nature of the research projects involved. These agreements could vary in scope, duration, and specific provisions, depending on the respective research focus or intended usage of the collateral. The types of San Jose, California Collateral License Agreements may include agreements specific to biomedical research, pharmaceutical development, genetic studies, or any other field of science where collaboration between Gentling, Inc. and The University of North Texas Health Science Center is required. By having a detailed Collateral License Agreement, both Gentling, Inc. and The University of North Texas Health Science Center can foster a productive partnership, protect their rights, and ensure the responsible management and utilization of the collateral generated through their joint efforts.
San Jose, California, Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center: The San Jose, California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding contract that governs the use and licensing of collateral created as a result of their collaborative research efforts. This agreement establishes the intellectual property rights and usage rights associated with the collateral, ensuring fair and mutually beneficial terms for both parties involved. In this agreement, Gentling, Inc. grants The University of North Texas Health Science Center a license to use and commercialize any collateral generated through their joint research projects. The collateral may include but is not limited to patents, copyrights, trademarks, trade secrets, and other forms of intellectual property. The agreement outlines the specific terms and conditions regarding the use, disclosure, and protection of this collateral. The purpose of this agreement is to formalize the relationship between Gentling, Inc. and The University of North Texas Health Science Center, ensuring that both parties have a clear understanding of their rights and obligations regarding the collateral. By establishing a licensing framework, it enables the university to further develop and commercialize the collateral, while also acknowledging Gentling, Inc.'s contribution to its creation. Furthermore, this collaborative agreement lays out the financial terms, including potential royalties or compensation that may be due to Gentling, Inc. based on the commercial success of the collateral. It also addresses confidentiality and non-disclosure provisions to protect any sensitive information shared during the research process. Different types of San Jose, California Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may exist depending on the nature of the research projects involved. These agreements could vary in scope, duration, and specific provisions, depending on the respective research focus or intended usage of the collateral. The types of San Jose, California Collateral License Agreements may include agreements specific to biomedical research, pharmaceutical development, genetic studies, or any other field of science where collaboration between Gentling, Inc. and The University of North Texas Health Science Center is required. By having a detailed Collateral License Agreement, both Gentling, Inc. and The University of North Texas Health Science Center can foster a productive partnership, protect their rights, and ensure the responsible management and utilization of the collateral generated through their joint efforts.